SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-206701
Filing Date
2020-07-31
Accepted
2020-07-31 17:20:53
Documents
4
Period of Report
2020-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d948005d8k.htm 8-K 24307
2 EX-4.1 d948005dex41.htm EX-4.1 78244
3 EX-10.1 d948005dex101.htm EX-10.1 107375
4 EX-10.2 d948005dex102.htm EX-10.2 46342
  Complete submission text file 0001193125-20-206701.txt   257729
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 201066945
SIC: 2834 Pharmaceutical Preparations